Girl's life saved by novel therapy for drug-resistant TB
Belgian physicians report they have cured a young patient with extensively drug-resistant tuberculosis (XDR-TB) using a novel two-drug combination developed by researchers at Albert Einstein College of...
View ArticleA drug combination extends survival in refractory lung cancer patients
Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies. They found that bexarotene...
View ArticleGene fault could predict ovarian cancer drug success
Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to research at...
View ArticleNew drug combination slows tumor growth for recurrent ovarian cancer
Bevacizumab (Avastin) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer, according to a new study. Results from the phase III "OCEANS" trial...
View ArticleNovel drug combination offers therapeutic promise for hard-to-treat cancers
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective...
View ArticleTARDIS trial seeks new dimension in stroke treatment
People who suffer from acute stroke or Transient Ischaemic Attack (TIA, a mini stroke) could get better treatment in the future thanks to the expansion of a large clinical trial of a new combination of...
View ArticleDrug combination highly effective for newly diagnosed myeloma patients, study...
(Medical Xpress) -- A three-drug combination treatment for the blood cancer multiple myeloma compares favorably to the best established therapy for newly diagnosed patients, according to a multi-center...
View ArticleTrial for new drug-resistant TB treatment to begin
A global health alliance Monday unveiled plans for the first clinical tests of a new treatment regimen for tuberculosis, including for patients with resistance to existing multidrug programs.
View ArticleTwo drugs already on the market show promise against tuberculosis
A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) a disease that kills 2 million people annually a scientist reported today at the 243...
View ArticleCombination drug treatment can cut malaria by 30 percent
Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.
View ArticleHarmless human virus may be able to boost the effects of chemotherapy
A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer...
View ArticleAdvances in personalized medicine for lung cancer
Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference...
View ArticleFirst, do no harm: Study finds danger in standard treatment for a serious...
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease,...
View ArticlePsychostimulant users seek information, not drugs, online
Australian illicit drug users are turning to the internet for drug education, but not to buy drugs.
View ArticleDrug combo much better than AZT alone at preventing mother-to-infant HIV...
Non-breastfed babies born to HIV-positive mothers who didn't receive antiretroviral therapy during pregnancy are routinely given zidovudine, commonly known as AZT, shortly after birth to prevent...
View ArticleNext front in worldwide AIDS battle: Stretching use of anti-HIV drugs
(Medical Xpress) -- A Johns Hopkins expert in the drug treatment of HIV disease and AIDS is spearheading an international effort to radically shift the manufacturing and prescribing of combination...
View ArticleScientists: Novel TB drug combo passes first test
Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it is resistant to today's two...
View ArticleMillions of Americans have uncontrolled high blood pressure: CDC
(HealthDay)—One-third of Americans have high blood pressure and only half of them have it under control, dramatically increasing their risk for possibly fatal heart attacks and strokes, a new...
View ArticleExperimental drug could help reduce brain damage, improve motor skills after...
(Medical Xpress)—A University of Arizona professor is overseeing the manufacture of an experimental drug that could help reduce brain damage after a stroke.
View ArticleNew malaria drug requires just one dose and appears twice as effective as...
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease...
View Article
